Federico Carbone

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Ischemia Reperfusion Injury

Top Venues

Cardiovascular research

European heart journal

Clinical kidney journal

This page only lists publications with an associated author ORCID identifier.

Publications

Federico Carbone, Atbin Djamshidian
Impulse Control Disorders in Parkinson's Disease: An Overview of Risk Factors, Pathogenesis and Pharmacological Management. CNS drugs 38 (6) (2024)
Federico Carbone, Atbin Djamshidian
Impulse Control Disorders in Parkinson's Disease: An Overview of Risk Factors, Pathogenesis and Pharmacological Management. CNS drugs 38 (6) (2024)
Federico Carbone, Atbin Djamshidian
Impulse Control Disorders in Parkinson's Disease: An Overview of Risk Factors, Pathogenesis and Pharmacological Management. CNS drugs (2024)
Alberto Preda, Fabrizio Montecucco, Federico Carbone, Giovanni G Camici, Thomas F Lüscher, Simon Kraler, Luca Liberale
SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits. Cardiovascular research 120 (5) (2024)
Srividya Velagapudi, Gergely Karsai, Maria Karsai, Shafeeq A Mohammed, Fabrizio Montecucco, Luca Liberale, Hwan Lee, Federico Carbone, Giovanni Francesco Adami, Kangmin Yang, Margot Crucet, Sokrates Stein, Franceso Paneni, Tetiana Lapikova-Bryhinska, Hyun-Duk Jang, Simon Kraler, Daria Vdovenko, Richard Arnold Züllig, Giovanni G Camici, Hyo-Soo Kim, Reijo Laaksonen, Philipp A Gerber, Thorsten Hornemann, Alexander Akhmedov, Thomas Felix Lüscher
Inhibition of de novo ceramide synthesis by Sirtuin-1 improves beta-cell function and glucose metabolism in type 2 diabetes. Cardiovascular research (2024)
Gema Frühbeck, Luca Busetto, Federico Carbone
The obesity syndemic in the European community: towards a systems thinking approach for preventive policies. European heart journal 45 (25) (2024)
Gema Frühbeck, Luca Busetto, Federico Carbone
The obesity syndemic in the European community: towards a systems thinking approach for preventive policies. European heart journal (2024)
Alberto Preda, Fabrizio Montecucco, Federico Carbone, Giovanni G Camici, Thomas F Lüscher, Simon Kraler, Luca Liberale
SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits. Cardiovascular research (2024)
Elisa Russo, Valentina Zanetti, Lucia Macciò, Giulia Benizzelli, Federico Carbone, Edoardo La Porta, Pasquale Esposito, Daniela Verzola, Giacomo Garibotto, Francesca Viazzi
SGLT2 inhibition to target kidney aging. Clinical kidney journal 17 (5) (2024)
Alberto Preda, Fabrizio Montecucco, Federico Carbone, Giovanni G Camici, Thomas F Lüscher, Simon Kraler, Luca Liberale
SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits. Cardiovascular research 120 (5) (2024)
Elisa Russo, Valentina Zanetti, Lucia Macciò, Giulia Benizzelli, Federico Carbone, Edoardo La Porta, Pasquale Esposito, Daniela Verzola, Giacomo Garibotto, Francesca Viazzi
SGLT2 inhibition to target kidney aging. Clinical kidney journal 17 (5) (2024)
Federico Carbone, Atbin Djamshidian
Impulse Control Disorders in Parkinson's Disease: An Overview of Risk Factors, Pathogenesis and Pharmacological Management. CNS drugs 38 (6) (2024)
Alberto Preda, Fabrizio Montecucco, Federico Carbone, Giovanni G Camici, Thomas F Lüscher, Simon Kraler, Luca Liberale
SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits. Cardiovascular research 120 (5) (2024)
Philipp Ellmerer, Marina Peball, Federico Carbone, Marcel Ritter, Beatrice Heim, Kathrin Marini, Dora Valent, Florian Krismer, Werner Poewe, Atbin Djamshidian, Klaus Seppi
Eye Tracking in Patients with Parkinson's Disease Treated with Nabilone-Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot Study. Brain sciences 12 (5) (2022)
Federico Carbone, Laura Zamarian, Verena Rass, Stefanie Bair, Marcel Ritter, Ronny Beer, Philipp Mahlknecht, Beatrice Heim, Victoria Limmert, Marina Peball, Philipp Ellmerer, Alois Josef Schiefecker, Mario Kofler, Anna Lindner, Bettina Pfausler, Lauma Putnina, Philipp Kindl, Judith Löffler-Ragg, Stefan Kiechl, Klaus Seppi, Atbin Djamshidian, Raimund Helbok
Cognitive dysfunction 1 year after COVID-19: evidence from eye tracking. Annals of clinical and translational neurology 9 (11) (2022)
Federico Carbone, Philipp Ellmerer, Marcel Ritter, Sabine Spielberger, Philipp Mahlknecht, Eva Hametner, Anna Hussl, Anna Hotter, Roberta Granata, Klaus Seppi, Sylvia Boesch, Werner Poewe, Atbin Djamshidian
Impaired Inhibitory Control of Saccadic Eye Movements in Cervical Dystonia: An Eye-Tracking Study. Movement disorders : official journal of the Movement Disorder Society 36 (5) (2021)